Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia

Conditions:   Sickle Cell Anemia in Children;   Malaria Intervention:   Drug: Dihydroartemisinin Piperaquine Sponsors:   Liverpool School of Tropical Medicine;   University of Bergen;   University of Malawi;   Makerere University;   Indiana University;   Global Health Uganda LTD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials